In the past five years, interventional cardiology has entered a new era of evaluating percutaneous transcatheter technologies to treat coronary artery disease and prevent restenosis. Cardiologists attempting to follow this field may be confused by the growth and expansion of new devices, the technical details relevant to each device and enthusiastic claims of success.
In the past five years, interventional cardiology has entered a new era of evaluating percutaneous transcatheter technologies to treat coronary artery...
From the Foreword by Eric J. Topol In the past five years, interventional cardiology has entered a new era of evaluating percutaneous transcatheter technologies to treat coronary artery disease and prevent restenosis. Cardiologists attempting to follow this new and exciting field may easily be confused by the growth and expansion of new devices, the technical details relevant to each device and enthusiastic claims of success. This monograph is a comprehensive and objective assessment of restenosis from the perspective of these new technologies including stenting, atherectomy,...
From the Foreword by Eric J. Topol In the past five years, interventional cardiology has entered a new era of evaluating percutaneous...
